Borreliosis versus Lyme -Time for a Divorce

[Camp Other]

Re: Borreliosis versus Lyme -Time for a Divorce
Post by Pandora » Sat 1 Jun 2013 5:59

HIV gp120 and OspA are the same thing, and you can't make a vaccine out of it. They failed -- all of them. Thailand with their est. 30K. reporting an AIDS LIKE illness, and countless other failures they stole our money for.
There does not seem to be any other toxin that does what Pam3Cys does, and we find it as the main antigens in HIV and Lyme.

I think I recognize the above gibberish. It looks like it’s from LymeNut Kathleen Dickson of Connecticut. So either Pandora is this unfortunate felon and mental patient or he/she has been reading her stuff.
http://www.lymeneteurope.org/forum/view ... son#p26631

Henrietta Lacks had syphilis.
When they biopsied her cells during surgery and make them into cell lines, they took some of the Treponema spirochetes with them in those cells.
These cells were shared around the world and many labs have them.
These cells were used in vaccine development.
Therefore Treponema spirochetes were incorporated into vaccines.
And it isn't just these spirochetes - no, it's other things which have cross-contaminated HeLa, and therefore contaminated vaccines.
And these vaccines could trigger prion development in their host.

So according to Pandora, everyone who has ever had a vaccine is essentially screwed. They develop autism or they develop Alzheimer's or they develop some other awful problem.

Pop quiz time.
Question 1. T. pallidum is an A) intracellular or B) extracellular pathogen?
Question 2. What two compounds are routinely added to cell/tissue culture media to prevent bacterial growth? Hint: one begins with P, the other with S.

Actually, Pandora's hypothesis is mentioned on more than one anti-vaccination promoting web site. She needn't go to Ms. Dickson's site to read about OspA. Go ahead, google "HeLa" and "vaccines" and "contamination" and see what you get.

Pandora has yet to provide evidence needed to support this hypothesis, and demonstrate all these variables line up.

And I'd like to request that she start a new thread on her hypothesis and leave this one to be about the classification and naming of Borrelia spp. - what it was originally about in the first place.

[Pandora]

What evidence do you need? The fact is well known Henrietta Lacks had Syphilis.
Are you refuting this too?

AND YES, as far as us being everywhere. Because we are trying to save people instead of letting them kill the people with lies of protections that NEVER WORKED once they infected us all with gene sharing stealth.

Because IT is now being carried generations to cause all syndromes
=
The scientists’ analysis of the HeLa genome revealed widespread abnormalities in both the number and structure of chromosomes, as well as factors commonly associated with cancer cells like losing healthy copies of genes.

In particular, the researchers found that countless regions of the chromosomes in each cell were arranged in the wrong order

and had extra or fewer copies of genes.

This is a telltale sign of chromosome shattering, a recently discovered phenomenon associated with 2-3% of all cancers. Knowledge of the genetic landscape of these cells can inform the design of future studies using HeLa cells, and strengthen the biological conclusions that can be made from them.
http://www.embl.de/aboutus/communicatio ... index.html

http://www.ncbi.nlm.nih.gov/pubmed/22544270
Borrelia burgdorferi cp32 BpaB modulates expression of the prophage NucP nuclease and SsbP single-stranded DNA-binding protein.

What part of the over 80% of the pops infected did you just not get from the worlds leading virologist, discoverer of HIV and now the discoverer of the real cause of AIDS?
http://www.youtube.com/watch?v=ubSnxCr7kz8

Word games are sooo over. As well as vaccines that never prevented any disease.

In fact France is drastically reducing their vaccines as we speak.
http://www.ncbi.nlm.nih.gov/pubmed/23782853
BMC Fam Pract. 2013 Jun 19;14(1):85. [Epub ahead of print]

[Pandora]

And just so you know I don't believe in gibberish when it comes to saving millions of lives!!! But NO I am Not Ms.Dickson, but I wish I was. She has been at the helm of reporting the science across the globe for decades for the truth which is why many countries are reporting those truths as Germany reports the DNA damages caused by HeLa and other IMMORTAL cell lines they used without telling you why they were IMMORTAL as well as the true causes of Cancers---INFECTIONS.

" I think I recognize the above gibberish. It looks like it’s from LymeNut Kathleen Dickson of Connecticut. So either Pandora is this unfortunate felon and mental patient or he/she has been reading her stuff."
viewtopic.php?f=6&t=440&p=26631&hilit=dickson#p26631

WHERE was ILADS when the fraud of Lyme Vaccines was on the table?

No where to be found, because they had rather be SILENT and keep chargeing you Lymies Thousands of dollars out of pocket than get on the truth train....

They could have pooled their resources and taken this all the way to the Supreme Court to stop the BS....but they chose not to to protect their own assets. Not the peoples.

Expanding the Prion Concept to Cancer Biology: Dominant-Negative Effect of Aggregates of Mutant p53 Tumor Suppressor.
http://www.ncbi.nlm.nih.gov/pubmed/23805941

35yrs. too late but wth....USA Medical Mafia is run by obstructionist murderers.

[Pandora]

The Lyme Vaccine Fraud. You thank whomever you want for NOT standing up for the people so you could get stuck with guidelines that never fit the stealth infections with the antigenic variation of the real cause of AIDS.

You can call them all the names you want, but not the people who tried to stop them from killing you with lies.

http://www.fda.gov/ohrms/dockets/ac/01/ ... 3680s2.htm

[X-member]

Should Patients Infected with Borrelia Burgdorferi No Longer Be Referred to as Having Lyme Disease?

Gary P. Wormser, M.D

https://www.amjmed.com/article/S0002-93 ... 0/fulltext

TinyUrl (if the link above don't work):

https://tinyurl.com/y93hzz7b

Two quotes:

.... we propose the name B. burgdorferi sensu lato infection, or Bbsl infection for short, instead of Lyme disease.

Microbiology taxonomists coincidently are arguing that Lyme borrelia should be referred to as Borreliella, reserving the term borrelia for relapsing fever type borrelia strains (e.g., B. hermsii).

[Anushka]

Public health and patient safety concerns merit retention of Lyme borreliosis-associated spirochetes within the genus Borrelia, and rejection of the genus novum Borreliella

Author links open overlay panel Brian Stevensonab VolkerFingerle Gary P.Wormser GabrieleMargos
Show more
https://doi.org/10.1016/j.ttbdis.2018.08.010

Following is a summary of the threats to public health that result from the renaming of Borrelia burgdorferi and other members of the species. We conclude with a recommendation that government, business, and medical authorities, as well as scientists and clinicians, use only the original genus name Borrelia for Lyme borreliosis- associated agents.

Lyme borreliosis (also called Lyme disease) is the most common arthropod-borne bacterial disease of humans in North America, Europe, and Asia. For example, an estimated 300,000 people become infected each year in the USA, and, according to health insurance data, over 200,000 cases of Lyme borreliosis occur every year in Germany (Müller et al., 2012; Nelson et al., 2015; Radolf et al., 2012; Schwartz et al., 2017; Stanek and Strle, 2003; Steere, 2001; Sykes and Makiello, 2017). In recent years, there have been substantial expansions of the range of the tick vector in North America, leading to increased incidence of human infections (Khatchikian et al., 2015; Stone et al., 2017).

Symptoms of Lyme borreliosis can vary widely among patients and may include characteristic skin lesions, arthritis, meningitis, radiculoneuritis, facial nerve paralysis, ocular involvement, and atrioventricular nodal block (Forrester and Mead, 2014; Hegerova and Olson, 2014; Kuchynka et al., 2015; Pinto, 2002; Robinson et al., 2015; Stanek and Strle, 2003; Steere, 2001). Failure to treat this infection during the early stages of infection can result in later clinical manifestations that may be more difficult to treat, such as Lyme arthritis and acrodermatitis chronica atrophicans. A missed or delayed diagnosis of Lyme carditis might even contribute to patient mortality (Forrester and Mead, 2014; Koene et al., 2012; Shenthar et al., 2014; Stanek and Strle, 2003; Steere, 2001; Yoon et al., 2015).

After its discovery during the early 1980s, the causative agent of Lyme borreliosis was named Borrelia burgdorferi (Burgdorfer et al., 1982; Johnson et al., 1984). Subsequent investigations led to its division into several genospecies, e.g., B. burgdorferi (sensu stricto), B. afzelii, B. garinii, and others. Also existing within the genus Borrelia are agents
of avian spirochetosis (B. anserina, the type species of the genus); soft tick-borne relapsing fever (B. hermsii, B. duttonii, and others, vectored by argasid ticks); louse-borne relapsing fever (B. recurrentis); B. miyamotoi, the agent of a disease that is distinct from Lyme borreliosis but vectored by the same tick species of the Ixodes ricinus-persulcatus species complex; and a large number of Borrelia genospecies with unknown human pathogenicity that are tick-transmitted and associated with tortoises, snakes, echidnas, and other vertebrates (Cutler et al., 2017). The chromosomes of the Lyme borreliosis agents are largely syntenic with those of the tick-borne relapsing fever Borrelia species, with the same gene orders and only 21 protein-coding genes (out of approximately 840) being specifically present only in one or the other group (Adeolu and Gupta, 2014; Pettersson et al., 2007). In addition, the type species of the genus Borrelia, B. anserina, lacks three genes that are contained by every other sequenced member of the genus, namely glpA, glpF, and glpK (Elbir et al., 2017). Moreover, the majority of Borrelia species have yet to be characterized at a genomic level, so the extent of diversity among these bacteria is not known.

A proposal was recently presented to split the spirochetes that cause Lyme borreliosis, and others within an undefined range of genomic similarity, into a new genus, Borreliella (Adeolu and Gupta, 2014). Other members of the genus Borrelia were to remain in the original genus. We note that the revised nomenclature does not invalidate the previously established nomenclature; for example, the same bacterium can validly be called either Borrelia burgdorferi or Borreliella burgdorferi.

As with many other bacteria, it is difficult to decide how different two organisms have to be before they are placed in separate species or genera. Arguments based on genetic similarities and differences can be made for and against the division of Borrelia (Barbour et al., 2017; Margos et al., 2017). However, changing the name of a pathogenic microorganism is not permitted if it poses a risk to public health and patient safety (nomen periculosum, as per Rule 56a of the International Code of Nomenclature of Prokaryotes) (Parker et al., 2015). Following this guidance, we describe safety concerns pertaining to changing the genus name of Lyme borreliosis-causing spirochetes:

1. Lyme borreliosis and Borrelia are thoroughly intertwined in medical references. It is imperative that physicians and other care givers receive prompt and accurate information when diagnosing and treating patients. New information on treatment recommendations or diagnostic tests is frequently published. From discovery onward, all publications on Lyme borreliosis describe the causative bacteria as members of the genus Borrelia. Only the paper on renaming the genus (Adeolu and Gupta, 2014), and fewer than ten others, even mention the word “Borreliella.”

2. Throughout the world, countless databases store diagnostic and treatment information. Search algorithms are usually based on keyword matches in order to retrieve the requested information. Thus, a search for Borreliella will likely fail to identify information that uses the name Borrelia, and vice versa. There is significant potential that such a failure could lead to diagnostic confusion and sub-optimal patient treatment, increasing the possibility of poor outcomes for patients. Overcoming this problem would require replacement of every database and/or access program throughout the world, which is not a practical solution. The possible risk to human health far outweighs any benefit of the proposed bacterial species name change.

3. In some countries, payment for the delivery of diagnostic testing services and clinical care to patients is highly dependent upon the use of standardized, precise disease codes and procedural codes (e.g. ICD-10, CPT in the USA). Such coding in hospitals, clinics, health care systems and insurance companies is indeed based on the terminology “Borrelia.” Inconsistencies in coding and related descriptors in computer systems, along with debates about whether or not Borreliella burgdorferi is the same causative agent as Borrelia burgdorferi, present genuine risks of confusion, denial of claims, and delay in proper insurance coverage. Consequently, access to diagnosis and treatment may be compromised, which could endanger the patient’s health.

4. Government regulations differ around the world. Similarly, health insurance coverages and procedures vary extensively. A diagnostic test or treatment regimen with approved use for treating infections by Borrelia burgdorferi sensu lato may not automatically be accepted for Borreliella burgdorferi. In such cases, a patient may be denied treatment or misdiagnosed. Again, this potential threat to human health needs to be of primary concern.

5. Lyme borreliosis is considered to be a professional risk in many countries for persons working in forested or grassy areas. Specific diagnosis and treatment are often covered by professional insurance programs; debates about Borreliella as being the same as Borrelia has the potential to delay proper insurance coverage and, consequently, diagnosis and treatment. This endangers the patient’s health and – by consequence – further employment.
In summary, a change of the genus name of spirochetes that cause Lyme borreliosis from Borrelia to any other name is likely to create great confusion and has the potential to harm patients.

We urge the responsible authorities to establish the following names (that are now listed in the List of Prokaryotic Names with Standing in Nomenclature) as nomen periculosa and reject their validations: Borreliella burgdorferi, Borreliella garinii, Borreliella bavariensis, Borreliella carolinensis, Borreliella japonica, Borreliella kurtenbachii, Borreliella sinica, and Borreliella spielmanii, as well as any other application of the genus name Borreliella. For those same reasons, we urge government, business, and medical authorities, as well as scientists and clinicians, to use only the original genus name Borrelia for Lyme borreliosis-associated spirochetes.

[X-member]

Could possibly Burgdorferi borreliosis work?

[Anushka]

Borreliosis is actually just the name equalling Lyme Disease. As in Germany Lyme Disease is known as Borreliose.

Has nothing to do with the proposition to add in the Prokaryotic Names with Standing in Nomenclature Borreliella. It was added by Adeolu and Gupta 2015, gen. nov. . I have never heard this name before. So I looked it up. http://www.bacterio.net/-allnamesac.html

Maybe someone who is familiar with Adeolu and Gupta and the whole discussion can shed some more light on this?

Here is the list.

Prokaryotic Names with Standing in Nomenclature

¤ Borrelia Swellengrebel 1907 (Approved Lists 1980), genus.
Borrelia afzelii Canica et al. 1994, sp. nov.
Borrelia americana Rudenko et al. 2010, sp. nov.
Borrelia anserina (Sakharoff 1891) Bergey et al. 1925 (Approved Lists 1980), species.
Borrelia baltazardii corrig. (ex Karimi et al. 1979) Karimi et al. 1983, sp. nov., nom. rev.
Borrelia bavariensis Margos et al. 2013, sp. nov.
Borrelia bissettiae Margos et al. 2016, sp. nov.
Borrelia brasiliensis Davis 1952 (Approved Lists 1980), species.
Borrelia burgdorferi Johnson et al. 1984, sp. nov.
Borrelia californiensis Margos et al. 2016, sp. nov.
Borrelia carolinensis Rudenko et al. 2011, sp. nov.
Borrelia caucasica (Kandelaki 1945) Davis 1957 (Approved Lists 1980), species.
Borrelia coriaceae Johnson et al. 1987, sp. nov.
Borrelia crocidurae (Leger 1917) Davis 1957 (Approved Lists 1980), species.
Borrelia dugesii (Mazzotti 1949) Davis 1957 (Approved Lists 1980), species.
Borrelia duttonii (Novy and Knapp 1906) Bergey et al. 1925 (Approved Lists 1980), species.
Borrelia garinii Baranton et al. 1992, sp. nov.
Borrelia graingeri (Heisch 1953) Davis 1957 (Approved Lists 1980), species.
Borrelia harveyi (Garnham 1947) Davis 1948 (Approved Lists 1980), species.
Borrelia hermsii (Davis 1942) Steinhaus 1946 (Approved Lists 1980), species.
Borrelia hispanica (de Buen 1926) Steinhaus 1946 (Approved Lists 1980), species.
Borrelia japonica Kawabata et al. 1994, sp. nov.
Borrelia kurtenbachii Margos et al. 2014, sp. nov.
Borrelia lanei Margos et al. 2017, sp. nov.
Borrelia latyschewii (Sofiev 1941) Davis 1948 (Approved Lists 1980), species.
Borrelia lusitaniae Le Fleche et al. 1997, sp. nov.
Borrelia mayonii Pritt et al. 2016, sp. nov.
Borrelia mazzottii Davis 1956 (Approved Lists 1980), species.
Borrelia miyamotoi Fukunaga et al. 1995, sp. nov.
Borrelia parkeri (Davis 1942) Steinhaus 1946 (Approved Lists 1980), species.
Borrelia persica (Dschunkowsky 1913) Steinhaus 1946 (Approved Lists 1980), species.
Borrelia recurrentis (Lebert 1874) Bergey et al. 1925 (Approved Lists 1980), species.
Borrelia sinica Masuzawa et al. 2001, sp. nov.
Borrelia spielmanii Richter et al. 2006, sp. nov.
Borrelia tanukii Fukunaga et al. 1997, sp. nov.
Borrelia theileri (Laveran 1903) Bergey et al. 1925 (Approved Lists 1980), species.
Borrelia tillae Zumpt and Organ 1961 (Approved Lists 1980), species.
Borrelia turcica Güner et al. 2004, sp. nov.
Borrelia turdi corrig. Fukunaga et al. 1997, sp. nov.
Borrelia turicatae (Brumpt 1933) Steinhaus 1946 (Approved Lists 1980), species.
Borrelia valaisiana Wang et al. 1997, sp. nov.
Borrelia venezuelensis (Brumpt 1921) Brumpt 1922 (Approved Lists 1980), species.
Borrelia yangtzensis Margos et al. 2015, sp. nov.

image

¤ Borreliaceae Gupta et al. 2014, fam. nov.

image

¤ Borreliella Adeolu and Gupta 2015, gen. nov.
Borreliella bavariensis Adeolu and Gupta 2015, comb. nov.
Borreliella burgdorferi Adeolu and Gupta 2015, comb. nov.
Borreliella carolinensis Adeolu and Gupta 2015, comb. nov.
Borreliella garinii Adeolu and Gupta 2015, comb. nov.
Borreliella japonica Adeolu and Gupta 2015, comb. nov.
Borreliella kurtenbachii Adeolu and Gupta 2015, comb. nov.
Borreliella sinica Adeolu and Gupta 2015, comb. nov.
Borreliella spielmanii Adeolu and Gupta 2015, comb. nov.

[Anushka]

As this arguement is actually a discussion about RF-like and LB spirochaetes ecological and genetic differences and not the name Borreliosis verses Lyme disease, adming should maybe split this thread up ?

https://www.researchgate.net/profile/Vo ... rrelia.pdf

[X-member]

If someone didn't understand my earlier post, I suggested Burgdorferi borreliosis instead of both Lyme disease and Borreliosis and I did this because some people have objections to Borreliella.